Derived from Current Agreements, our editors have selected notable M&A deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.
For comprehensive access to all life science deals as they are announced:
Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now
Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now
Featured M&A deals
All M&A deals: Deal Monitor | Current Agreements
Valeant ups offer and secures Salix; Endo withdraws
March 17, 2015 : big pharma, M&A, Valeant
Valeant increased the offer price to acquire all the outstanding common stock of Salix from $158.00 per share to $173.00 per share more »
GlaxoSmithKline sells Aspen Pharmacare $853 million equity stake
March 16, 2015 : big pharma, GlaxoSmithKline, M&A
GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings more »
Endo makes counter bid for Salix
March 12, 2015 : big pharma, M&A
Concordia Healthcare stumps up $1.2bn for Covis Pharma assets
March 10, 2015 : asset purchase, M&A, partnering
Abbvie acquires Pharmacyclics for $21 billion
March 9, 2015 : AbbVie, big pharma, M&A
AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica (ibrutinib), a highly effective treatment for hematologic malignancies more »
Mallinckrodt acquires Ikaria for $2.3bn
March 5, 2015 : M&A
Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion more »
Baxter acquires Suppremol for $225 million
March 5, 2015 : Baxter, big pharma, M&A
Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments more »
Nikon acquires Optos for $400 million
March 2, 2015 : M&A, medical device
Shire acquires Meritage Pharma for $70 million
February 26, 2015 : M&A, shire
Shire has acquired Meritage for an upfront fee of $70 million and additional contingent payments more »
Sorin and Cyberonics to merge
February 26, 2015 : M&A
Derived from Current Agreements, more featured partnering deals by category:
Big pharma
AstraZeneca and Innate Pharma in IPH2201 deal
April 28, 2015
Celgene and AstraZeneca in MEDI4736 pact
April 28, 2015
Teva bids to acquire Mylan as Perrigo rejects approach
April 22, 2015
Big biotech
Genzyme and Voyager in $845 million AAV gene therapy pact
February 12, 2015
Pharma
Lilly snags rights to Erbitux from BMS
April 20, 2015
Ventana and Astellas in automated tissue diagnostics pact
April 15, 2015
Biotech
Curis and Aurigene in immuno-oncology pact
January 22, 2015
Agile Therapeutics bags $20 million in private placement
January 21, 2015
Celgene licenses AG-120 from Agios
January 14, 2015
Diagnostics
LabCorp has acquired Covance for $6.1 billion
November 4, 2014
In m&a news: Optum has bought Alere Health for $600 million
October 30, 2014
Medical device
BTG acquires emphysema innovator PneumRx
December 5, 2014
Conventus Orthopaedics banks series AA financing for $24 million
December 4, 2014
Xeltis secures series B financing for $34 million
December 3, 2014
Drug delivery
M&A news: Acorda has purchased Civitas Therapeutics
September 25, 2014
NeuroDerm files for $250 million in IPO financing
September 17, 2014
Foamix Pharma files for $75 million in IPO financing
August 15, 2014
